	The Association Between the Aggregate Index of Systemic Inflammation (AISI) and Prevalence of Psoriasis: Cross Sectional NHANES Study 2003-2006 and 2009-2014. Exp Dermatol Zhao Y, Song J, Shen L, Chen B, Cai J, Yu Y, Yang L, Xi J, Qi L. PMID: 41732102 [PubMed - indexed for MEDLINE]
	On-label persistence in psoriasis after switching to guselkumab, tumor necrosis factor inhibitors, interleukin-17 inhibitors, or apremilast from other advanced therapies. J Dermatolog Treat Zhdanava M, Fitzgerald T, Boonmak P, Pilon D, Schwartzbein S, Libchaber B, Feldman SR. PMID: 41732098 [PubMed - indexed for MEDLINE]
	Increased risk of inflammatory bowel disease in ankylosing spondylitis compared to psoriasis. Front Immunol He Z, Zhang YN, Wei JC, Dai SM. PMID: 41727477 [PubMed - indexed for MEDLINE]
	Sex hormone-psoriasis interactions: from sex-specific clinical features to immunoregulatory mechanisms. Front Immunol Dai Y, Wang Y, Huang Y, Jiang X, Tan J. PMID: 41727453 [PubMed - indexed for MEDLINE]
	Toward the definition of moderate psoriasis: an expert opinion. J Dermatolog Treat Costanzo A, Bardazzi F, Burlando M, Campanati A, Carrera C, Dapavo P, Galluzzo M, Gargiulo L, Gisondi P, Loconsole F, Malagoli P, Megna M, Micali G, Piaserico S. PMID: 41725608 [PubMed - indexed for MEDLINE]
	Assessing Targeted Proteomics in Inflammatory Skin Diseases with the Tape-stripping Method. Acta Derm Venereol Vinge AS, Altintas S, Ødum N, Johansen JD, Løvendorf MB, Skov L. PMID: 41725456 [PubMed - indexed for MEDLINE]
	Vision transformer-based diagnosis of psoriasis and eczema in whole-slide histology. Virchows Arch Rivera Monroy LC, Petzold A, Sari M, Breininger K, Maier A, Vera-Gonzalez J, Erdmann M, Schliep S, Drexler K, Niebel D, Schreml S, Hayani KM, Aebischer V, Braun SA, Schmidle P, Metze D, Sticherling M, Berking C, Koch EAT, Heppt MV. PMID: 41714431 [PubMed - as supplied by publisher]
	Ixekizumab for the treatment of psoriatic arthritis: an Italian multicentric retrospective observational study. Sci Rep Gentileschi S, Terribili R, Gaggiano C, Fiorentini E, Cometi L, Cigolini C, Perrotta FM, Scriffignano S, Di Cato L, Panaccione A, Niccoli L, Cantini F, Benucci M, Li Gobbi F, Delle Sedie A, Vitale A, Lubrano E, Frediani B, Guiducci S. PMID: 41714331 [PubMed - in process]
	A Randomized Clinical Trial: The Comparative Therapeutic Efficacy of Tap Water-UVA, Saltwater-UVA, and Conventional Bath PUVA in Palmoplantar Pustulosis. Photodermatol Photoimmunol Photomed K, Gündo, Botsal, Kar , Kundakç, Erdem C. PMID: 41712670 [PubMed - indexed for MEDLINE]
	Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE Study. Dermatol Ther (Heidelb) Trovato E, Bonifati C, Ribero S, Scalvenzi M, Narcisi A, Cuccia A, Panasiti V, Richetta AG, Pagnanelli G, Peris K, Rongioletti F, Satolli F, Bardazzi F, Borghi A, Carrera C, Galluzzo M, Lasagni C, Moretti G, Romanelli M, Cozzani E, Guarneri C, Venturini M, Bongiorno MR, Prignano F, Di Lernia V, Taviti F, Persechino S, De Pasquale R, Colonna F, Talamonti M, Costanzo A. PMID: 41712057 [PubMed - as supplied by publisher]
	Macronutrient intakes and associations with psoriasis severity: a cross-sectional analysis of the asking people with psoriasis about lifestyle and eating (APPLE) study. Eur J Nutr Zanesco S, Maruthappu T, Griffiths CEM, Zhang R, Dalrymple KV, Gibson R, Hall WL. PMID: 41711966 [PubMed - in process]
	Persistence and Long-Term Disease Control of Interleukin-17 Inhibitors and Interleukin-23 Inhibitors in Patients with Psoriasis: A Nationwide Cohort Study in Japan. Psoriasis (Auckl) Xu Y, Li T, Chang CL, Zhang Y, Masuda J, Wu GH, Wahking B, Imafuku S, Qiu H. PMID: 41710906 [PubMed]
	Nanocarriers for Psoriasis Treatment: Insights from a Clinical Trial Registered on the Global Clinical Trials Registry Platform. Int J Nanomedicine Tang S, Xiao R, Zeng Z, Xi J. PMID: 41710365 [PubMed - indexed for MEDLINE]
	Sustained improvements in health status and work productivity with bimekizumab in psoriatic arthritis: 2-year results from two phase 3 studies. Rheumatol Adv Pract Tillett W, Gossec L, Husni ME, Morita A, Ink B, Bajracharya R, Healy P, Mørup MF, Walsh JA. PMID: 41710044 [PubMed]
	Budget Impact of Secukinumab in Psoriatic Arthritis Patients with Contraindication to TNF-Alpha Inhibitors. Clinicoecon Outcomes Res Permsuwan U, Dilokthornsakul P, Sawangjit R. PMID: 41710018 [PubMed]
	IL-23 Inhibitors in Psoriasis: What Have We Learnt so Far? J Inflamm Res Megna M, D'Agostino M, Feo F, Ventura V, Tommasino N, Potestio L. PMID: 41709961 [PubMed]
	Comparison of treatment with GP2017 (an adalimumab biosimilar) and reference adalimumab in people with plaque psoriasis: a plain language summary of the ADACCESS trial. Immunotherapy Betteridge N, Blauvelt A, Edgerton C, Fan J, Guerrieri D, Rose L, Brueckmann I, Wang Q. PMID: 41709696 [PubMed - as supplied by publisher]
	Guttate Psoriasis Triggered by Streptococcal Pharyngitis in Older Patients: A Case Report. Am J Case Rep Thomas DE, Gunasekharan A, Yallapragada RK. PMID: 41709535 [PubMed - indexed for MEDLINE]
	IL-23 serum levels and IL23R polymorphisms in psoriasis: a meta-analysis of susceptibility and severity. BMC Immunol Ahmadipanah S, Shariat Rad P, Montaseri M, Nemati H, Sadeghi M, Ramezani M. PMID: 41709148 [PubMed - as supplied by publisher]
	Rational Design of Imidazo[1,2-a]pyridine as an Effective TLR7 Antagonist for the Treatment of Psoriasis: Research Combined with In Silico Study. J Med Chem Yao P, Li X, Li G, Song M, Yu T, Zheng Z, Zhao Y, Li J, Wang D, Zhu Y, Hou Y, Ding J, Shen H, Zhang G, Ji M, Yang H, Li P, Liu Z, Yang P. PMID: 41708477 [PubMed - as supplied by publisher]

Articles 1 - 20 / 27492

Page 1 of 1375



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy